Palatin Technologies has announced updated results from responder analyses of its pivotal Phase 3 Me...
read moreAce Vision Group (AVG) has announced the successful closing of a $29.4 million Series B financing ro...
read moreUNITY Biotechnology has announced that NEJM Evidence has published results from the Phase 2 BEHOLD s...
read moreiStar Medical has announced positive 5-year results from the STAR-GLOBAL trial evaluating the long-t...
read moreBausch + Lomb has identified the root cause of a recent voluntary recall of select intraocular lense...
read moreVivaVision Biotech has announced positive topline results from its Phase 2 clinical trial of VVN461,...
read moreEntod Pharmaceuticals has received marketing authorization from the Central Drugs Standard Control O...
read moreZhaoke Ophthalmology has announced the enrollment of the first patient in its Phase 3 clinical trial...
read moreMicrosurgical Technology (MST) has announced a strategic partnership with Japanese manufacturer Mani...
read moreThe U.S. Food and Drug Administration (FDA) has accepted Regeneron’s supplemental Biologics License ...
read more